<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36745901</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1948-7193</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>ACS chemical neuroscience</Title><ISOAbbreviation>ACS Chem Neurosci</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Spike Protein Downregulates Cell Surface &#x3b1;7nAChR through a Helical Motif in the Spike Neck.</ArticleTitle><Pagination><StartPage>689</StartPage><EndPage>698</EndPage><MedlinePgn>689-698</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschemneuro.2c00610</ELocationID><Abstract><AbstractText>A deficiency of the functional &#x3b1;7 nicotinic acetylcholine receptor (&#x3b1;7nAChR) impairs neuronal and immune systems. The SARS-CoV-2 spike protein (S12) facilitates virus cell entry during COVID-19 infection and can also independently disrupt cellular functions. Here, we found that S12 expression significantly downregulated surface expression of &#x3b1;7nAChR in mammalian cells. A helical segment of S12 (L1145-L1152) in the spike neck was identified to be responsible for the downregulation of &#x3b1;7nAChR, as the mutant S12<sub>AAA</sub> (L1145A-F1148A-L1152A) had minimal effects on surface &#x3b1;7nAChR expression. This S12 segment is homologous to the &#x3b1;7nAChR intracellular helical motif known for binding chaperone proteins RIC3 and Bcl-2 to promote &#x3b1;7nAChR surface expression. Competition from S12 for binding these proteins likely underlies suppression of surface &#x3b1;7nAChR. Considering the critical roles of &#x3b1;7nAChR in cellular functions, these findings provide a new perspective for improving mRNA vaccines and developing treatment options for certain symptoms related to long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tillman</LastName><ForeName>Tommy S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bondarenko</LastName><ForeName>Vasyl</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Jonathan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Structural Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Structural Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Pei</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2869-2737</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DA046939</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Neurosci</MedlineTA><NlmUniqueID>101525337</NlmUniqueID><ISSNLinking>1948-7193</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064569">alpha7 Nicotinic Acetylcholine Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064569" MajorTopicYN="Y">alpha7 Nicotinic Acetylcholine Receptor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mRNA vaccines</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword><Keyword MajorTopicYN="N">&#x3b1;7 nicotinic acetylcholine receptor</Keyword><Keyword MajorTopicYN="N">&#x3b1;7nAChR</Keyword></KeywordList><CoiStatement>The authors
declare the following competing financial interest(s): A patent application
covering mutations to the S12 L1145-L1152 segment has been submitted
by University of Pittsburgh with P.T., T.S.T., and Y.X. listed as
inventors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36745901</ArticleId><ArticleId IdType="pmc">PMC9923440</ArticleId><ArticleId IdType="doi">10.1021/acschemneuro.2c00610</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taquet M.; Sillett R.; Zhu L.; Mendel J.; Camplisson I.; Dercon Q.; Harrison P. J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry 2022, 9, 815.10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021, 27 (1), 28&#x2013;33. 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore J. B.; June C. H. Cytokine release syndrome in severe COVID-19. Science 2020, 368 (6490), 473&#x2013;474. 10.1126/science.abb8925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J.; Kremer S.; Merdji H.; Clere-Jehl R.; Schenck M.; Kummerlen C.; Collange O.; Boulay C.; Fafi-Kremer S.; Ohana M.; et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J. Med. 2020, 382 (23), 2268&#x2013;2270. 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A.; Sehgal K.; Gupta A.; Madhavan M. V.; McGroder C.; Stevens J. S.; Cook J. R.; Nordvig A. S.; Shalev D.; Sehrawat T. S.; et al. Post-acute COVID-19 syndrome. Nat. Med. 2021, 27 (4), 601&#x2013;615. 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.; Huang L.; Wang Y.; Li X.; Ren L.; Gu X.; Kang L.; Guo L.; Liu M.; Zhou X.; et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021, 397 (10270), 220&#x2013;232. 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S.; Williams M. A. Confronting Our Next National Health Disaster - Long-Haul Covid. N Engl J. Med. 2021, 385 (7), 577&#x2013;579. 10.1056/NEJMp2109285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E. L.; Clark J. R.; Orban Z. S.; Lim P. H.; Szymanski A. L.; Taylor C.; DiBiase R. M.; Jia D. T.; Balabanov R.; Ho S. U.; et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin Transl Neurol 2021, 8 (5), 1073&#x2013;1085. 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M.; Luciano S.; Geddes J. R.; Harrison P. J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2021, 8 (2), 130&#x2013;140. 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T. C. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?. Mol. Neurobiol 2022, 59 (3), 1850&#x2013;1861. 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Avolio E.; Carrabba M.; Milligan R.; Kavanagh Williamson M.; Beltrami A. P.; Gupta K.; Elvers K. T.; Gamez M.; Foster R. R.; Gillespie K.; et al. The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease. Clin Sci. (Lond) 2021, 135 (24), 2667&#x2013;2689. 10.1042/CS20210735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20210735</ArticleId><ArticleId IdType="pmc">PMC8674568</ArticleId><ArticleId IdType="pubmed">34807265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N.; Zuo Y.; Yalavarthi S.; Hunker K. L.; Knight J. S.; Kanthi Y.; Obi A. T.; Ganesh S. K. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism. Viruses 2021, 13 (11), 2209.10.3390/v13112209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112209</ArticleId><ArticleId IdType="pmc">PMC8617813</ArticleId><ArticleId IdType="pubmed">34835015</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R. D.; Barry M. A.; Croatt A. J.; Ackerman A. W.; Grande J. P.; Diaz R. M.; Vile R. G.; Agarwal A.; Nath K. A. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications. Biochim Biophys Acta Mol. Basis Dis 2022, 1868 (3), 166322.10.1016/j.bbadis.2021.166322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2021.166322</ArticleId><ArticleId IdType="pmc">PMC8669938</ArticleId><ArticleId IdType="pubmed">34920080</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles J. P.; Zamora M.; Adan-Castro E.; Siqueiros-Marquez L.; Martinez de la Escalera G.; Clapp C. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin alpha5beta1 and NF-kappaB signaling. J. Biol. Chem. 2022, 298 (3), 101695.10.1016/j.jbc.2022.101695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101695</ArticleId><ArticleId IdType="pmc">PMC8820157</ArticleId><ArticleId IdType="pubmed">35143839</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L.; Morigi M.; Galbusera M.; Pezzotta A.; Gastoldi S.; Imberti B.; Perna A.; Ruggenenti P.; Donadelli R.; Benigni A.; et al. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation. Front Immunol 2022, 13, 827146.10.3389/fimmu.2022.827146.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.827146</ArticleId><ArticleId IdType="pmc">PMC8936079</ArticleId><ArticleId IdType="pubmed">35320941</ArticleId></ArticleIdList></Reference><Reference><Citation>Changeux J. P.; Amoura Z.; Rey F. A.; Miyara M. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. C R Biol. 2020, 343 (1), 33&#x2013;39. 10.5802/crbiol.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.5802/crbiol.8</ArticleId><ArticleId IdType="pubmed">32720486</ArticleId></ArticleIdList></Reference><Reference><Citation>Couturier S.; Bertrand D.; Matter J. M.; Hernandez M. C.; Bertrand S.; Millar N.; Valera S.; Barkas T.; Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 1990, 5 (6), 847&#x2013;856. 10.1016/0896-6273(90)90344-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(90)90344-F</ArticleId><ArticleId IdType="pubmed">1702646</ArticleId></ArticleIdList></Reference><Reference><Citation>Albuquerque E. X.; Pereira E. F.; Alkondon M.; Rogers S. W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009, 89 (1), 73&#x2013;120. 10.1152/physrev.00015.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00015.2008</ArticleId><ArticleId IdType="pmc">PMC2713585</ArticleId><ArticleId IdType="pubmed">19126755</ArticleId></ArticleIdList></Reference><Reference><Citation>Letsinger A. C.; Gu Z.; Yakel J. L. alpha7 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity. Trends Neurosci 2022, 45 (2), 145&#x2013;157. 10.1016/j.tins.2021.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.11.006</ArticleId><ArticleId IdType="pmc">PMC8914277</ArticleId><ArticleId IdType="pubmed">34916082</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlov V. A.; Wang H.; Czura C. J.; Friedman S. G.; Tracey K. J. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 2003, 9 (5&#x2013;8), 125&#x2013;134. (PMID: 14571320)10.1007/BF03402177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03402177</ArticleId><ArticleId IdType="pmc">PMC1430829</ArticleId><ArticleId IdType="pubmed">14571320</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlov V. A.; Tracey K. J. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005, 19 (6), 493&#x2013;499. 10.1016/j.bbi.2005.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2005.03.015</ArticleId><ArticleId IdType="pubmed">15922555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat. Rev. Drug Discov 2005, 4 (8), 673&#x2013;684. 10.1038/nrd1797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1797</ArticleId><ArticleId IdType="pubmed">16056392</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F. X.; Zhao L. Q.; Zhu R. N.; Song Q. W.; Deng J.; Tian R.; Wang F.; Qian Y. Protective effect of an alpha 7 nicotinic acetylcholine receptor agonist against enterovirus 71 infection in neuronal cells. Antiviral Res. 2018, 149, 106&#x2013;112. 10.1016/j.antiviral.2017.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.10.007</ArticleId><ArticleId IdType="pubmed">29024766</ArticleId></ArticleIdList></Reference><Reference><Citation>Schloss M. J.; Hulsmans M.; Rohde D.; Lee I. H.; Severe N.; Foy B. H.; Pulous F. E.; Zhang S.; Kokkaliaris K. D.; Frodermann V.; et al. B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis. Nat. Immunol 2022, 23 (4), 605&#x2013;618. 10.1038/s41590-022-01165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01165-7</ArticleId><ArticleId IdType="pmc">PMC8989652</ArticleId><ArticleId IdType="pubmed">35352063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H.; George S. J.; Thompson D. A.; Silverman H. A.; Tsaava T.; Tynan A.; Pavlov V. A.; Chang E. H.; Andersson U.; Brines M.; et al. Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm. Mol. Med. 2022, 28 (1), 57.10.1186/s10020-022-00483-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00483-8</ArticleId><ArticleId IdType="pmc">PMC9109205</ArticleId><ArticleId IdType="pubmed">35578169</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudim M.; Qadri Y. J.; Ghadimi K.; MacLeod D. B.; Molinger J.; Piccini J. P.; Whittle J.; Wischmeyer P. E.; Patel M. R.; Ulloa L. Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19. J. Cardiovasc Transl Res. 2020, 13 (6), 894&#x2013;899. 10.1007/s12265-020-10031-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-020-10031-6</ArticleId><ArticleId IdType="pmc">PMC7250255</ArticleId><ArticleId IdType="pubmed">32458400</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.; Yu M.; Ochani M.; Amella C. A.; Tanovic M.; Susarla S.; Li J. H.; Wang H.; Yang H.; Ulloa L.; et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421 (6921), 384&#x2013;388. 10.1038/nature01339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01339</ArticleId><ArticleId IdType="pubmed">12508119</ArticleId></ArticleIdList></Reference><Reference><Citation>Bencherif M.; Lippiello P. M.; Lucas R.; Marrero M. B. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell. Mol. Life Sci. 2011, 68 (6), 931&#x2013;949. 10.1007/s00018-010-0525-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-010-0525-1</ArticleId><ArticleId IdType="pmc">PMC3678737</ArticleId><ArticleId IdType="pubmed">20953658</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlov V. A.; Tracey K. J. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat. Neurosci 2017, 20 (2), 156&#x2013;166. 10.1038/nn.4477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4477</ArticleId><ArticleId IdType="pubmed">28092663</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradi J.; Bouzat C. Understanding the Bases of Function and Modulation of alpha7 Nicotinic Receptors: Implications for Drug Discovery. Mol. Pharmacol. 2016, 90 (3), 288&#x2013;299. 10.1124/mol.116.104240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.116.104240</ArticleId><ArticleId IdType="pubmed">27190210</ArticleId></ArticleIdList></Reference><Reference><Citation>Lendvai B.; Kassai F.; Szajli A.; Nemethy Z. alpha7 nicotinic acetylcholine receptors and their role in cognition. Brain Res. Bull. 2013, 93, 86&#x2013;96. 10.1016/j.brainresbull.2012.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2012.11.003</ArticleId><ArticleId IdType="pubmed">23178154</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotti C.; Zoli M.; Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 2006, 27 (9), 482&#x2013;491. 10.1016/j.tips.2006.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2006.07.004</ArticleId><ArticleId IdType="pubmed">16876883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrachi T.; Vaknin-Dembinsky A.; Brenner T.; Treinin M. Neuroinflammation Modulation via alpha7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3. Molecules 2021, 26 (20), 6139.10.3390/molecules26206139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26206139</ArticleId><ArticleId IdType="pmc">PMC8539643</ArticleId><ArticleId IdType="pubmed">34684720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q.; Yakel J. L. The effect of alpha7 nicotinic receptor activation on glutamatergic transmission in the hippocampus. Biochem. Pharmacol. 2015, 97 (4), 439&#x2013;444. 10.1016/j.bcp.2015.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2015.07.015</ArticleId><ArticleId IdType="pmc">PMC4600449</ArticleId><ArticleId IdType="pubmed">26212541</ArticleId></ArticleIdList></Reference><Reference><Citation>Koukouli F.; Maskos U. The multiple roles of the alpha7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system. Biochem. Pharmacol. 2015, 97 (4), 378&#x2013;387. 10.1016/j.bcp.2015.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2015.07.018</ArticleId><ArticleId IdType="pubmed">26206184</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman R.; Hall M.; Adler L. E.; Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 1995, 38 (1), 22&#x2013;33. 10.1016/0006-3223(94)00252-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-3223(94)00252-X</ArticleId><ArticleId IdType="pubmed">7548469</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange K. W.; Wells F. R.; Jenner P.; Marsden C. D. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson&#x2019;s disease. J. Neurochem 1993, 60 (1), 197&#x2013;203. 10.1111/j.1471-4159.1993.tb05838.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb05838.x</ArticleId><ArticleId IdType="pubmed">8417140</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotti C.; Moretti M.; Bohr I.; Ziabreva I.; Vailati S.; Longhi R.; Riganti L.; Gaimarri A.; McKeith I. G.; Perry R. H.; et al. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis 2006, 23 (2), 481&#x2013;489. 10.1016/j.nbd.2006.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.04.005</ArticleId><ArticleId IdType="pubmed">16759874</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo M.; Mulet J.; Gutierrez L. M.; Ortiz J. A.; Castelan F.; Gerber S.; Sala S.; Sala F.; Criado M. Dual role of the RIC-3 protein in trafficking of serotonin and nicotinic acetylcholine receptors. J. Biol. Chem. 2005, 280 (29), 27062&#x2013;27068. 10.1074/jbc.M503746200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M503746200</ArticleId><ArticleId IdType="pubmed">15927954</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawe G. B.; Yu H.; Gu S.; Blackler A. N.; Matta J. A.; Siuda E. R.; Rex E. B.; Bredt D. S. alpha7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nat. Commun. 2019, 10 (1), 2746.10.1038/s41467-019-10723-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10723-x</ArticleId><ArticleId IdType="pmc">PMC6588605</ArticleId><ArticleId IdType="pubmed">31227712</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L.; Kannapadi N. V.; Briggs J.; Seal S. M.; Battaglini D.; Fanning J.; Suen J.; Robba C.; Fraser J.; Cho S. M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol Sci. 2022, 434, 120162.10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Boix V.; Merino E. Post-COVID syndrome. The never ending challenge. Med. Clin (Engl Ed) 2022, 158 (4), 178&#x2013;180. 10.1016/j.medcle.2021.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcle.2021.10.005</ArticleId><ArticleId IdType="pmc">PMC8801902</ArticleId><ArticleId IdType="pubmed">35128063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangaran P. G.; Ibrahim Z. A.; Chik Z.; Mohamed Z.; Ahmadiani A. Lipopolysaccharide Pre-conditioning Attenuates Pro-inflammatory Responses and Promotes Cytoprotective Effect in Differentiated PC12 Cell Lines via Pre-activation of Toll-Like Receptor-4 Signaling Pathway Leading to the Inhibition of Caspase-3/Nuclear Factor-kappaappa B Pathway. Front Cell Neurosci 2021, 14, 598453.10.3389/fncel.2020.598453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.598453</ArticleId><ArticleId IdType="pmc">PMC7862565</ArticleId><ArticleId IdType="pubmed">33551748</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J. A.; Gu S.; Davini W. B.; Bredt D. S. Nicotinic acetylcholine receptor redux: Discovery of accessories opens therapeutic vistas. Science 2021, 373 (6556), eabg6539.10.1126/science.abg6539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg6539</ArticleId><ArticleId IdType="pubmed">34385370</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S.; Matta J. A.; Lord B.; Harrington A. W.; Sutton S. W.; Davini W. B.; Bredt D. S. Brain alpha7 Nicotinic Acetylcholine Receptor Assembly Requires NACHO. Neuron 2016, 89 (5), 948&#x2013;955. 10.1016/j.neuron.2016.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.01.018</ArticleId><ArticleId IdType="pubmed">26875622</ArticleId></ArticleIdList></Reference><Reference><Citation>Halevi S.; Yassin L.; Eshel M.; Sala F.; Sala S.; Criado M.; Treinin M. Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression. J. Biol. Chem. 2003, 278 (36), 34411&#x2013;34417. 10.1074/jbc.M300170200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M300170200</ArticleId><ArticleId IdType="pubmed">12821669</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobeil S. M.; Janowska K.; McDowell S.; Mansouri K.; Parks R.; Manne K.; Stalls V.; Kopp M. F.; Henderson R.; Edwards R. J.; et al. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction. Cell Rep 2021, 34 (2), 108630.10.1016/j.celrep.2020.108630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108630</ArticleId><ArticleId IdType="pmc">PMC7762703</ArticleId><ArticleId IdType="pubmed">33417835</ArticleId></ArticleIdList></Reference><Reference><Citation>Riganti L.; Matteoni C.; Di Angelantonio S.; Nistri A.; Gaimarri A.; Sparatore F.; Canu-Boido C.; Clementi F.; Gotti C. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 2005, 146 (8), 1096&#x2013;1109. 10.1038/sj.bjp.0706434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0706434</ArticleId><ArticleId IdType="pmc">PMC1751242</ArticleId><ArticleId IdType="pubmed">16273122</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar N. S. RIC-3: a nicotinic acetylcholine receptor chaperone. Br. J. Pharmacol. 2008, 153 (Suppl. 1), S177&#x2013;183. 10.1038/sj.bjp.0707661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0707661</ArticleId><ArticleId IdType="pmc">PMC2268041</ArticleId><ArticleId IdType="pubmed">18246096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kweon H. J.; Gu S.; Witham E.; Dhara M.; Yu H.; Mandon E. D.; Jawhari A.; Bredt D. S. NACHO Engages N-Glycosylation ER Chaperone Pathways for alpha7 Nicotinic Receptor Assembly. Cell Rep 2020, 32 (6), 108025.10.1016/j.celrep.2020.108025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108025</ArticleId><ArticleId IdType="pubmed">32783947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor K.; Chen T.; Tajkhorshid E. Posttranslational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors. Proc. Natl. Acad. Sci. U. S. A. 2022, 119 (28), e2119761119.10.1073/pnas.2119761119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2119761119</ArticleId><ArticleId IdType="pmc">PMC9282386</ArticleId><ArticleId IdType="pubmed">35737823</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider C. A.; Rasband W. S.; Eliceiri K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9 (7), 671&#x2013;675. 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien O.; Wells J. A. Caspases and their substrates. Cell Death Differ. 2017, 24 (8), 1380&#x2013;1389. 10.1038/cdd.2017.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.44</ArticleId><ArticleId IdType="pmc">PMC5520456</ArticleId><ArticleId IdType="pubmed">28498362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenboim L.; Diamond R.; Rothenberg E.; Stein R. Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle. Cancer Res. 1995, 55 (6), 1242&#x2013;1247. (PMID: 7533660).</Citation><ArticleIdList><ArticleId IdType="pubmed">7533660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruman I.; Guo Q.; Mattson M. P. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci Res. 1998, 51 (3), 293&#x2013;308. 10.1002/(SICI)1097-4547(19980201)51:3&lt;293::AID-JNR3&gt;3.0.CO;2-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19980201)51:3&lt;293::AID-JNR3&gt;3.0.CO;2-B</ArticleId><ArticleId IdType="pubmed">9486765</ArticleId></ArticleIdList></Reference><Reference><Citation>Egea J.; Buendia I.; Parada E.; Navarro E.; Leon R.; Lopez M. G. Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. Biochem. Pharmacol. 2015, 97 (4), 463&#x2013;472. 10.1016/j.bcp.2015.07.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2015.07.032</ArticleId><ArticleId IdType="pubmed">26232730</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh E. E.; Frenck R. W. Jr.; Falsey A. R.; Kitchin N.; Absalon J.; Gurtman A.; Lockhart S.; Neuzil K.; Mulligan M. J.; Bailey R.; et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J. Med. 2020, 383 (25), 2439&#x2013;2450. 10.1056/NEJMoa2027906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2027906</ArticleId><ArticleId IdType="pmc">PMC7583697</ArticleId><ArticleId IdType="pubmed">33053279</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett K. S.; Edwards D. K.; Leist S. R.; Abiona O. M.; Boyoglu-Barnum S.; Gillespie R. A.; Himansu S.; Schafer A.; Ziwawo C. T.; DiPiazza A. T.; et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 2020, 586 (7830), 567&#x2013;571. 10.1038/s41586-020-2622-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2622-0</ArticleId><ArticleId IdType="pmc">PMC7581537</ArticleId><ArticleId IdType="pubmed">32756549</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira A. S. F.; Ibarra A. A.; Bermudez I.; Casalino L.; Gaieb Z.; Shoemark D. K.; Gallagher T.; Sessions R. B.; Amaro R. E.; Mulholland A. J. A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors. Biophys. J. 2021, 120 (6), 983&#x2013;993. 10.1016/j.bpj.2021.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.01.037</ArticleId><ArticleId IdType="pmc">PMC7889469</ArticleId><ArticleId IdType="pubmed">33609494</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrestia J. F.; Oliveira A. S.; Mulholland A. J.; Gallagher T.; Bermudez I.; Bouzat C. A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human alpha7 Nicotinic Receptor. Mol. Neurobiol 2022, 59 (10), 6076&#x2013;6090. 10.1007/s12035-022-02947-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02947-8</ArticleId><ArticleId IdType="pmc">PMC9299415</ArticleId><ArticleId IdType="pubmed">35859025</ArticleId></ArticleIdList></Reference><Reference><Citation>Farley J.; Anderson J. B. SARS-CoV-2 S1 spike protein peptides inhibit alpha 7 nAChRs and are counteracted by a PAM at alpha 7. Biophys. J. 2022, 121 (3), 386a&#x2013;387a. 10.1016/j.bpj.2021.11.826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.11.826</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F.; Li J.; Wang P. H.; Yang N.; Huang J.; Ou J.; Xu T.; Zhao X.; Liu T.; Huang X.; et al. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim Biophys Acta Mol. Basis Dis 2021, 1867 (12), 166260.10.1016/j.bbadis.2021.166260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2021.166260</ArticleId><ArticleId IdType="pmc">PMC8390448</ArticleId><ArticleId IdType="pubmed">34461258</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant S. N.; Lester H. A. Regulation of epithelial sodium channel activity by SARS-CoV-1 and SARS-CoV-2 proteins. Biophys. J. 2021, 120 (14), 2805&#x2013;2813. 10.1016/j.bpj.2021.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.06.005</ArticleId><ArticleId IdType="pmc">PMC8238646</ArticleId><ArticleId IdType="pubmed">34197807</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigang S.; Fuchs J.; Zimmer G.; Schnepf D.; Kern L.; Beer J.; Luxenburger H.; Ankerhold J.; Falcone V.; Kemming J.; et al. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants. Nat. Commun. 2021, 12 (1), 6405.10.1038/s41467-021-26602-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26602-3</ArticleId><ArticleId IdType="pmc">PMC8568958</ArticleId><ArticleId IdType="pubmed">34737266</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B.; Choudhary M. C.; Regan J.; Sparks J. A.; Padera R. F.; Qiu X.; Solomon I. H.; Kuo H. H.; Boucau J.; Bowman K.; et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J. Med. 2020, 383 (23), 2291&#x2013;2293. 10.1056/NEJMc2031364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z.; Senussi Y.; Manickas-Hill Z.; Yu X. G.; Li J. Z.; Alter G.; Walt D. R. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis 2022, 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y.; Kellar K. J. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. J. Pharmacol Exp Ther 2004, 310 (1), 98&#x2013;107. 10.1124/jpet.104.066787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.104.066787</ArticleId><ArticleId IdType="pubmed">15016836</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X.; Katz M.; Gerzanich V.; Anand R.; Lindstrom J. Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol. Pharmacol. 1994, 45 (3), 546&#x2013;554. (PMID: 8145738).</Citation><ArticleIdList><ArticleId IdType="pubmed">8145738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryksin A. V.; Matsumura I. Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids. Biotechniques 2010, 48 (6), 463&#x2013;465. 10.2144/000113418.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/000113418</ArticleId><ArticleId IdType="pmc">PMC3121328</ArticleId><ArticleId IdType="pubmed">20569222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh C. L.; Goldsmith J. A.; Schaub J. M.; DiVenere A. M.; Kuo H. C.; Javanmardi K.; Le K. C.; Wrapp D.; Lee A. G.; Liu Y.; et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 2020, 369 (6510), 1501&#x2013;1505. 10.1126/science.abd0826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd0826</ArticleId><ArticleId IdType="pmc">PMC7402631</ArticleId><ArticleId IdType="pubmed">32703906</ArticleId></ArticleIdList></Reference><Reference><Citation>Koushik S. V.; Chen H.; Thaler C.; Puhl H. L. 3rd; Vogel S. S. Cerulean, Venus, and VenusY67C FRET reference standards. Biophys. J. 2006, 91 (12), L99&#x2013;L101. 10.1529/biophysj.106.096206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.106.096206</ArticleId><ArticleId IdType="pmc">PMC1779932</ArticleId><ArticleId IdType="pubmed">17040988</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul S. F.; Madden T. L.; Schaffer A. A.; Zhang J.; Zhang Z.; Miller W.; Lipman D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25 (17), 3389&#x2013;3402. 10.1093/nar/25.17.3389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/25.17.3389</ArticleId><ArticleId IdType="pmc">PMC146917</ArticleId><ArticleId IdType="pubmed">9254694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievers F.; Higgins D. G. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 2018, 27 (1), 135&#x2013;145. 10.1002/pro.3290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3290</ArticleId><ArticleId IdType="pmc">PMC5734385</ArticleId><ArticleId IdType="pubmed">28884485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>